Pharmacology of Baloxavir (Xofluza®); a First-in-Class Cap-dependent Endonuclease Inhibitor for Treatment of Influenza

Authors :: Shishido Takao
Source :: Proceedings for Annual Meeting of The Japanese Pharmacological Society. 93:2-LBS
Publication Year :: 2020
Publisher :: Japanese Pharmacological Society, 2020.

Subjects :: Endonuclease
Class (set theory)
biology
Applied Mathematics
General Mathematics
biology.protein
Pharmacology

ISSN :: 24354953
Volume :: 93
Database :: OpenAIRE
Journal :: Proceedings for Annual Meeting of The Japanese Pharmacological Society
Accession number :: edsair.doi...........bf2c7e5565a9c5ca349f08940f2ad314

Tools